Document and Entity Information
Document and Entity Information | Jun. 23, 2021 |
Cover [Abstract] | |
Amendment Flag | true |
Entity Central Index Key | 0001654151 |
Document Type | 8-K/A |
Document Period End Date | Jun. 23, 2021 |
Entity Registrant Name | Deciphera Pharmaceuticals, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-38219 |
Entity Tax Identification Number | 30-1003521 |
Entity Address, Address Line One | 200 Smith Street |
Entity Address, City or Town | Waltham |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02451 |
City Area Code | (781) |
Local Phone Number | 209-6400 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.01 Par Value |
Trading Symbol | DCPH |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Amendment Description | This Current Report on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K of Deciphera Pharmaceuticals, Inc. (the “Company”) filed with the U.S. Securities and Exchange Commission on June 25, 2021 (the “Original Form 8-K”). The Original Form 8-K reported the final voting results of the Company’s 2021 Annual Meeting of Stockholders held on June 23, 2021 (the “2021 Annual Meeting”). The sole purpose of this Amendment is to disclose the Company’s decision regarding how frequently it will conduct future stockholder non-binding advisory votes on the compensation of the Company’s named executive officers (“Say-on-Pay Votes”). No other changes have been made to the Original Form 8-K. |